These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 32699350)
1. Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment. Pan X; Zheng L Cell Mol Immunol; 2020 Sep; 17(9):940-953. PubMed ID: 32699350 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of the tumor microenvironment. Marks DL; Olson RL; Fernandez-Zapico ME Epigenomics; 2016 Dec; 8(12):1671-1687. PubMed ID: 27700179 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462 [TBL] [Abstract][Full Text] [Related]
4. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Dai E; Zhu Z; Wahed S; Qu Z; Storkus WJ; Guo ZS Mol Cancer; 2021 Dec; 20(1):171. PubMed ID: 34930302 [TBL] [Abstract][Full Text] [Related]
5. DNA methylation in the tumor microenvironment. Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108 [TBL] [Abstract][Full Text] [Related]
6. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra. Cheng B; Yu Q; Wang W J Biomed Sci; 2023 Jan; 30(1):1. PubMed ID: 36600243 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment. Garcia-Gomez A; RodrÃguez-Ubreva J; Ballestar E Clin Immunol; 2018 Nov; 196():64-71. PubMed ID: 29501540 [TBL] [Abstract][Full Text] [Related]
8. The emerging role of epigenetic therapeutics in immuno-oncology. Topper MJ; Vaz M; Marrone KA; Brahmer JR; Baylin SB Nat Rev Clin Oncol; 2020 Feb; 17(2):75-90. PubMed ID: 31548600 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer. Li J; Yuan S; Norgard RJ; Yan F; Sun YH; Kim IK; Merrell AJ; Sela Y; Jiang Y; Bhanu NV; Garcia BA; Vonderheide RH; Blanco A; Stanger BZ Cancer Discov; 2021 Mar; 11(3):736-753. PubMed ID: 33158848 [TBL] [Abstract][Full Text] [Related]
10. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression. Saleh R; Toor SM; Sasidharan Nair V; Elkord E Front Immunol; 2020; 11():1469. PubMed ID: 32760400 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies. Trnkova L; Buocikova V; Mego M; Cumova A; Burikova M; Bohac M; Miklikova S; Cihova M; Smolkova B Biomed Pharmacother; 2024 May; 174():116559. PubMed ID: 38603889 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic changes in tumor microenvironment. Dey P Indian J Cancer; 2011; 48(4):507-12. PubMed ID: 22293269 [TBL] [Abstract][Full Text] [Related]
13. EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy. Sun S; Yu F; Xu D; Zheng H; Li M Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188700. PubMed ID: 35217116 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy. Kawakubo K; Castillo CF; Liss AS J Gastroenterol; 2022 Nov; 57(11):819-826. PubMed ID: 36048239 [TBL] [Abstract][Full Text] [Related]
15. Cancer Epigenetics, Tumor Immunity, and Immunotherapy. Cao J; Yan Q Trends Cancer; 2020 Jul; 6(7):580-592. PubMed ID: 32610068 [TBL] [Abstract][Full Text] [Related]
16. m Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities. Tien FM; Lu HH; Lin SY; Tsai HC J Biomed Sci; 2023 Jan; 30(1):3. PubMed ID: 36627707 [TBL] [Abstract][Full Text] [Related]
18. Emerging Epigenetic-Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment. Zhang J; Huang L; Ge G; Hu K Adv Sci (Weinh); 2023 Mar; 10(7):e2206169. PubMed ID: 36599655 [TBL] [Abstract][Full Text] [Related]
19. Understanding the Crosstalk Between Epigenetics and Immunometabolism to Combat Cancer. Seth A; Kar S Subcell Biochem; 2022; 100():581-616. PubMed ID: 36301507 [TBL] [Abstract][Full Text] [Related]
20. The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications. Zhu D; Zeng S; Su C; Li J; Xuan Y; Lin Y; Xu E; Fan Q Clin Epigenetics; 2024 Feb; 16(1):24. PubMed ID: 38331927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]